Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep384 | Endocrine-Related Cancer | ECE2021

Oncogenic role of splicing factor SRSF2/SC35 in pancreatic and prostate adenocarcinomas

Berbel Inmaculada , Alors-Perez Emilia , Juan M Jiménez-Vacas , Ricardo Blázquez-Encinas , Cristina Viyuela-García , Álvaro Arjona-Sanchez , Juan Manuel Sánchez-Hidalgo , Marina Sánchez-Frías , Enrique Gómez-Gómez , Ortiz Manuel Gahete , Alejandro Ibañez Costa , Luque Raul M. , Justo P. Castaño

IntroductionAlternative splicing allows the generation of multiple RNA isoforms from a single pre-RNA molecule, and thereby contributes to a multitude of physiological processes, but can also be involved in many diseases, including cancer. Indeed, disruption of alternative splicing has been linked to key cancer features, such as tumor growth, metastasis and hormone responsiveness and is increasingly regarded as a novel and transversal cancer hallmark. Th...

ea0073aep397 | Endocrine-Related Cancer | ECE2021

Anticancer activity of hydroxytyrosol and five semisynthetic lipophilic derivatives in prostate cancer cells

Antonio J. León-González , Prudencio Sáez-Martínez , Juan M. Jiménez-Vacas , Herrero-Aguayo Vicente , Antonio J. Montero-Hidalgo , Enrique Gómez-Gómez , Andrés Madrona , Justo P. Castaño , José L. Espartero , Gahete Manuel D. , Raúl M. Luque

Prostate cancer (PCa) is the second most diagnosed cancer type and the sixth cause of cancer death among men worldwide. Due to the usual slow course of the progression of this disease, there is a growing interest in finding chemopreventive therapeutics with a low risk of side effects. In line with this, recent studies have shown that hydroxytyrosol (HT), one of the main extra virgin olive oil phenolic compounds, exerts a protective role against different cancer types. Moreover...

ea0073aep454 | General Endocrinology | ECE2021

Acute pancreatitis in a covid-19 patient

Maria Zhao Montero Benítez , Pascual Cristina Contreras , Mendez Cristina Montalban , Tirado Antonio Moreno , Paloma González Lázaro , Florentino Del Val Zaballos , Julia Silva-Fernández , Meneses Amparo Lomas , Francisco Javier Gómez Alfonso , Inés Gómez García

Acute pancreatitis (AP) is an inflammatory disorder of the pancreas, most commonly caused by gallstones and heavy alcohol consumption. The diagnosis is established with at least 2 of the following criteria: abdominal pain; increased serum lipase/amylase levels greater than 3 times the upper limit of normal value; or characteristic findings on contrast computed tomography (CT). Since the beginning of the severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic, a few...

ea0073ep202 | Thyroid | ECE2021

Selpercatinib as an alternative therapy to Lenvatinib for metastatic medullary thyroid cancer. A case report.

Contreras Pascual Cristina , Montalban Mendez Cristina , Moreno Tirado Antonio , Maria Zhao Montero Benítez , Paloma González Lázaro , Julia Silva-Fernández , Florentino Del Val Zaballos , Francisco Javier Gómez Alfonso , Lomas Meneses Amparo , Inés Gómez García

Selpercatinib is a receptor tyrosine kinase RET inhibitor for the treatment of cancers such as RET-mutant medullary thyroid cancer, demonstrating partial response and low incidence of serious adverse events. Vandetanib, a tyrosine kinase inhibitor, has shown promising results with an increase in progression-free survival and prolonged lifetime, but it causes adverse events such as hypertension, diarrhea, rash, or long QT interval. Most of them are can be even disabling for the...

ea0081ep1002 | Thyroid | ECE2022

Hypothyroidism associated with treatment with immunotherapy: case series

Zhao Montero Benitez Maria , Gonzalez Lazaro Paloma , Mendez Cristina Montalban , Tirado Antonio Moreno , Torrecilla Pedro Jimenez , Zaballos Florentino Del Val , Meneses Amparo Lomas , Alfonso Francisco Javier Go mez , Iglesias Maria Lopez , Gomez Garcia Ines

Introduction: The development of immunotherapy has opened up a new approach in the management of different types of tumors that previously had not treatment, and its use is becoming increasingly widespread. Immunotherapy is based on blocking immune checkpoints involved in activating the immune response to malignant neoplasms. Since its introduction into clinical practice, several adverse effects related to the immune system have been reported. Among the endocrinological advers...

ea0070aep44 | Adrenal and Cardiovascular Endocrinology | ECE2020

Etiology and extent of impaired quality of life, fatigue and affective, cognitive, and emotional dysfunction in patients with cushing’s syndrome – The IQFACE-CS study

de Vries Friso , Papakokkinou Eleni , Santos Alicia , van Haalen Femke , Valassi Elena , Biermasz Nienke , Johansson Birgitta , Gómez-Ansón Beatriz , Bauduin Stéphanie , Resmini Eugenia , van der Wee Nic , Pereira Alberto M , Webb Susan , Ragnarsson Oskar

Background: Patients with Cushing’s Syndrome (CS) suffer from a variety of neuropsychiatric and cognitive problems. Following remission, some, but not all of these symptoms resolve. Recent cross-sectional studies in patients with CS show persistent structural and functional brain abnormalities. However, longitudinal studies using magnetic resonance imaging, and a detailed neurocognitive assessment, performed before and after treatment, are not available.<p class="abs...

ea0070aep279 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Association of FT3 levels and FT3/FT4 ratio in the first trimester with the risk of developing gestational diabetes

Isabel Álvarez Schettini María , Ruiz Ochoa David , Alberto Vázquez Salvi Luis , Higinio Ortega Sánchez Carlos , Alio Lavín Gómez Bernardo , Montalbán Carrasco Coral

Introduction: Gestational diabetes (GD) is one of the most common complications of pregnancy. Thyroid hormones play an important role in carbohydrate homeostasis, however, their influence on the risk of developing gestational diabetes has shown contradictory results.Objective: To explore whether variations in thyroid function parameters, within the thresholds of normality, can be associated with the risk of developing GD.Material a...

ea0070ep555 | Hot topics (including COVID-19) | ECE2020

Maturity-onset diabetes of the young type 5 (MODY 5): A case reporte

Contreras Pascual Cristina , González Lázaro Paloma , Montalbán Méndez Cristina , Moreno Tirado Antonio , Silva Fernández Julia , Gómez García Inés

The diagnosis of atypical non-autoimmune forms of diabetes mellitus, such as maturity onset diabetes of the young (MODY) presents several challenges, in view of the extensive clinical and genetic heterogeneity of the disease. In this report we describe a case of atypical non autoimmune diabetes associated with a damaging HNF1β mutation. A 39-years-old woman with normal weight (BMI 20’8 kg/m2), endometriosis, ex-smoker, fatty liver and uterus bicornis unic...

ea0014p226 | (1) | ECE2007

Frequency of hypogonadism in males with type 2 diabetes and its relation with erectile dysfunction and obesity

García-Malpartida Katherinne , Casañ-Fernández Rosa , Yanini-García Jesús , Jover-Fernández Ana , Gómez-Balaguer Marcelino , Solá-Izquierdo Eva , Morillas-Ariño Carlos , Hernández-Mijares Antonio

Introduction: The aim of our study was to determine the frequency of hypogonadism (H) in males with type 2 diabetes (T2D) and its relation with erectile dysfunction (ED) and obesity.Methods: We studied 107 diabetic males who came successively to an Endocrine consultation. The presence of H was determined by total testosterone (T) with an immunofluerescence method and free testosterone (fT) calculated with Vermeulen’s equation, defining H if T<2 ...

ea0073aep132 | Calcium and Bone | ECE2021

Bone mineral density evolution after Denosumab withdrawal

Mª Rosa Alhambra Expósito , Ana Barrera-Martín , Ángel Rebollo-Román , José Manuel Quesada Gómez , Maria Angeles Galvez Moreno

IntroductionDenosumab (Dab) withdrawal is associated with a quick loss in bone mineral density (BMD) and a high risk of multiple vertebral fractures. It is still not stablished which strategy best prevents BMD loss after Dab discontinuation.AimCompare the use of bisphosphonates for one year after Dab withdrawal versus a tapering Dab regimen in terms of BMD and fracture occurrence.Method...